What to expect from CONMED's (CNMD) Q3 earnings

What happened

CONMED, a medical tech company, will report earnings on Wednesday after the market closes. Last quarter it reported revenues of $343.5 million, flat year on year, and beat analysts' profit-per-share estimates. Analysts expect flat revenue this quarter.

Confirmed

Global impact / market context

Flat expected revenue means investors will likely focus on whether CONMED can keep beating profit-per-share estimates and guidance, because growth has stalled. If profits hold up despite flat sales, that suggests cost control is working and could support the stock after the report.

Analyst inference

Two peers in healthcare equipment and supplies have already reported: Intuitive Surgical grew revenue 21.7% and Neogen grew 6.5%, both beating estimates, yet each fell 2.3%. That pattern suggests strong results alone may not lift shares, so CONMED's stock reaction could depend on guidance.

Analyst inference

What to watch

1. Watch whether CONMED's reported revenue comes in flat year on year, as the market expects, after last quarter's $343.5 million and the 6.7% increase in the same quarter last year. Confirmed
2. Watch whether analysts reconfirm or change their estimates, since they have generally kept them steady over the last 30 days, suggesting they expect the business to stay on course. Proposed
3. Watch CONMED's profit-per-share result and any full-year guidance, because repeated beats there, rather than revenue growth, may be what supports the stock after peers fell despite beating estimates. Analyst inference

Evidence

• stockstory.org